Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

LON/0A9W stock hub

LON/0A9W has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0A9Wis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.6B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0A9W
In the news

Latest news · LON/0A9W

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E3.9
P25 n/aP50 n/aP75 n/a
Trailing P/E13.8
P25 n/aP50 n/aP75 n/a
ROE34
P25 n/aP50 n/aP75 n/a
ROIC6.5
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0A9W market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
217
Groups with data
11
Currency
USD
Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United States
Country code
UK
Employees
10,000
Employees Change
0%
Employees Change Percent
0
Enterprise value
$8B
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Isin
US68622V1061
Last refreshed
2026-05-10
Market cap
$2.6B
Price
$13.31
Price currency
USD
Rev Per Employee
466,727.07x
Sic
2834
Symbol
lon/0A9W
Website
https://www.organon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
7.24%
EV Earnings
43.17x
EV/EBIT
8.9x
EV/EBITDA
6.58x
EV/FCF
15.55x
EV/Sales
1.78x
FCF yield
20.1%
Forward P/E
3.95x
P/B ratio
3.76x
P/E ratio
13.81x
P/S ratio
0.55x
PE Ratio3 Y
5.58x
PE Ratio5 Y
5.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
19.99%
EBITDA Margin
25.88%
FCF margin
11.08%
Gross margin
53.84%
Gross Profit
$2.5B
Gross Profit Growth
-8.04%
Gross Profit Growth Q
-7.06%
Gross Profit Growth3 Y
-4.76%
Gross Profit Growth5 Y
-4.08%
Net Income
$186.3M
Net Income Growth
-67.2%
Net Income Growth Q
67.82%
Net Income Growth3 Y
-30.91%
Net Income Growth5 Y
-33.25%
Pretax Margin
8.71%
Profit Margin
3.99%
Profit Per Employee
$18,630
ROA
5.89
Roa5y
8.46
ROCE
11.74
ROE
34.05
ROIC
6.51
Roic5y
16.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr1y
46.57%
Cagr3y
-11.9%
Div CAGR3
-59.96%
EPS Growth
-67.25
EPS Growth Q
66.67
EPS Growth3 Y
-31.41
EPS Growth5 Y
-33.63
FCF Growth
-12.1%
FCF Growth Q
337.21%
FCF Growth3 Y
2.19%
FCF Growth5 Y
-24.43%
OCF Growth
-9.38%
OCF Growth Q
200%
OCF Growth3 Y
0.04%
OCF Growth5 Y
-22.42%
Revenue Growth
-2.08x
Revenue Growth Q
-3.5x
Revenue Growth3 Y
0.1x
Revenue Growth5 Y
-0.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$0.47
Assets
$9.8B
Cash
$845.2M
Current Assets
$3.6B
Current Liabilities
$1.8B
Debt
$6.5B
Debt EBITDA
$5.15
Debt Equity
$9.49
Debt FCF
$12.55
Equity
$683.8M
Interest Coverage
2.51
Liabilities
$9.2B
Long Term Assets
$6.2B
Long Term Liabilities
$7.3B
Net Cash
$-5.6B
Net Cash By Market Cap
$-219
Net Debt EBITDA
$4.67
Net Debt Equity
$8.25
Net Debt FCF
$10.91
Tangible Book Value
$-3.3B
Tangible Book Value Per Share
$-12.54
WACC
5.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.97
Inventory Turnover
2.08
Net Working Capital
$1B
Quick ratio
1
Working Capital
$1.8B
Working Capital Turnover
$2.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.55%
Dividend Growth
-93.2%
Dividend Growth Years
0%
Dividend per share
$0.06
Dividend Years
6
Dividend Yield
0.45%
Ex Div Date
2026-02-23
Last Dividend
$0.01
Payout Frequency
Quarterly
Payout Ratio
8.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
46.53%
200-day SMA
8.56
3Y total return
-31.63%
50-day SMA
8.37
50-day SMA vs 200-day SMA
50under200
All Time High
39.19
All Time High Change
-66.04%
All Time High Date
2022-03-02
All Time Low
5.71
All Time Low Change
133.1%
All Time Low Date
2026-03-30
ATR
0.51
Beta
1.55
Ch YTD
84.55
High
13.36
High52
13.42
High52 Date
2026-05-07
High52ch
-0.82%
Low
13.29
Low52
5.71
Low52 Date
2026-03-30
Low52ch
133.1%
Ma50ch
59.08%
Price vs 200-day SMA
55.42%
RSI
79.55
RSI Monthly
50.45
RSI Weekly
69.82
Sharpe ratio
0.91x
Sortino ratio
1.66
Total Return
-0.1%
Tr YTD
85.01
Tr1m
118.63%
Tr1w
0.15%
Tr3m
64.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
$933M
Operating Income Growth
-13.06
Operating Income Growth Q
-18.26
Operating Income Growth3 Y
-7.78
Operating Income Growth5 Y
-12.72
Operating margin
19.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
260,995,902%
Net Borrowing
-357,221,318
Shares Insiders
0.51%
Shares Institutions
77.46%
Shares Qo Q
1.05%
Shares Yo Y
0.55%
Short Ratio
2.05

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
$462.7M
Average Volume
83,108.8x
Bv Per Share
2.6
CAPEX
$-126.5M
Ch1m
118.6
Ch1w
0.15
Ch1y
45.13
Ch3m
64.3
Ch3y
-40.44
Ch6m
99.7
Change
-0.3%
Change From Open
-0.08
Close
13.35
Days Gap
-0.22
Depreciation Amortization
266,265,582
Dollar Volume
119,231
Earnings Date
2026-04-30
EBIT
$933M
EBITDA
$1.2B
EPS
$0.71
F Score
6
FCF
$517.2M
FCF EV Yield
6.43x
Financing CF
-396,827,820
Fiscal Year End
December
Founded
1,923
Goodwill
3,046,283,642
Graham Number
8.75889
Graham Upside
-34.19
Income Tax
$220.4M
Investing CF
127,227,240
Is Primary Listing
0
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Lynch Fair Value
$4.82
Lynch Upside
-63.79
Ma150
8.15
Ma150ch
63.31%
Ma20
11.24
Ma20ch
18.37%
Net CF
430,906,545
Open
13.32
P FCF Ratio
4.97
P OCF Ratio
4
Payment Date
2026-03-12
Position In Range
28.57
Ppne
938,164,406
Price Date
2026-05-08
Price EBITDA
$2.13
Relative Volume
0.11x
Revenue
4,667,270,715x
SBC By Revenue
1.17x
Share Based Comp
54,525,960
Tax By Revenue
4.72x
Tax Rate
54.19%
Tr6m
100.74%
Volume
8,958
Z Score
1.26
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

LON/0A9W dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.5%
$0.06 annual per share
Payout ratio
+8.9%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
-0.1%
Next ex-dividend date: 2026-02-23
Performance

LON/0A9W stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+46.5%
S&P 500 1Y: n/a
3Y total return
-31.6%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0A9W?

Insider, institutional, and short-interest positioning.

Institutional ownership
+77.5%
Share of float held by funds and institutions
Insider ownership
+0.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
2.1 days to cover
Y/Y dilution
+0.5%
Negative means the company is buying back shares.
Technical

LON/0A9W momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
79.5
Above 70: short-term overbought
Price vs 200-day MA
+55.4%
50/200-day relationship not available
Beta (5Y)
1.55
More volatile than the market
Sharpe ratio
0.91
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0A9W

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0A9W stock rating?

lon/0A9W is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0A9W analysis?

The full report lives at /stocks/lon/0A9W/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0A9W?

The latest report frames lon/0A9W around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0A9W page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.